Asset Details
MbrlCatalogueTitleDetail
Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex 1 pathway and may contribute to oral squamous cell carcinoma
/ Carcinoma, Squamous Cell - genetics
/ Carcinoma, Squamous Cell - metabolism
/ Carcinoma, Squamous Cell - pathology
/ Cell Proliferation - drug effects
/ Cholinergic Agonists - pharmacology
/ Cyclin-Dependent Kinase Inhibitor p21 - genetics
/ Cyclin-Dependent Kinase Inhibitor p21 - metabolism
/ Cyclin-Dependent Kinase Inhibitor p27 - genetics
/ Cyclin-Dependent Kinase Inhibitor p27 - metabolism
/ Down-Regulation - drug effects
/ G1 Phase Cell Cycle Checkpoints - drug effects
/ G2 Phase Cell Cycle Checkpoints - drug effects
/ Humans
/ Male
/ Mechanistic Target of Rapamycin Complex 1
/ Mouth Neoplasms - metabolism
/ Multiprotein Complexes - genetics
/ Multiprotein Complexes - metabolism
/ oral squamous cell carcinoma
/ Original
/ Reactive Oxygen Species - metabolism
/ Reverse Transcriptase Polymerase Chain Reaction
/ Signal Transduction - drug effects
/ TOR Serine-Threonine Kinases - genetics
/ TOR Serine-Threonine Kinases - metabolism
/ Vacuoles